Market Overview

Morgan Stanley Sees End-Market Pressure On Hill-Rom

Share:
Related HRC
Fast Money Halftime Report Final Trade From January 15
Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades
Dividend Champions For April 2015 (Seeking Alpha)

In a report published Tuesday, Morgan Stanley analyst David R. Lewis reiterated an Underweight rating and $36.00 price target on Hill-Rom Holdings (NYSE: HRC).

In the report, Morgan Stanley noted, “We are supportive of the deal, but remain underweight on end-market pressure. More diversity is needed, which will continually put valuation at risk, but the returns and channel leverage from the TRUMPF deal make us more positive than we were on Aspen.”

Hill-Rom closed on Monday at $40.09.

Latest Ratings for HRC

DateFirmActionFromTo
Jan 2015Bank of AmericaUpgradesUnderperform
Jan 2015Morgan StanleyUpgradesUnderweightEqualweight
Dec 2014Goldman SachsUpgradesBuyConviction Buy

View More Analyst Ratings for HRC
View the Latest Analyst Ratings

Posted-In: David R. Lewis Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HRC)

Around the Web, We're Loving...